101140.KS KSC
INBIOGEN Co., Ltd.
1W: -1.6%
1M: -13.5%
3M: -17.8%
YTD: -56.0%
1Y: -49.4%
3Y: -48.4%
5Y: -92.8%
₩4,820.00 ($3.59)
+140.00 (+2.99%)
Weekly Expected Move ±6.9%
₩4152
₩4486
₩4820
₩5154
₩5488
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$5.6B
-16663.8% ▼
Capital Expenditures
$43M
+49.6% ▲
5Y CAGR: -46.5%
Free Cash Flow
-$5.6B
-4666.7% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$4.8B
-1192.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $94.1B | -$119.7B | $18.9B | $16.1B | -$1.4B |
| Depreciation & Amort. | $1.1B | $1.4B | $1.2B | $1.1B | $363M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$2.6B | -$2.6B | $1.3B | $2.1B | -$2.5B |
| Other Non-Cash Items | -$99.7B | $109.4B | -$22.4B | -$19.3B | -$2.0B |
| Operating Cash Flow | -$7.1B | -$11.5B | -$1.1B | -$33M | -$5.6B |
| — Investing Activities — | |||||
| Capital Expenditures | -$2.4B | -$331M | -$26M | -$84M | -$43M |
| Acquisitions (Net) | $41M | -$240M | $64M | $0 | $65M |
| Investment Purchases | -$38.0B | -$30.5B | $0 | $0 | $0 |
| Investment Sales | $304K | $15.1B | $0 | $0 | $0 |
| Other Investing | -$77M | $70M | -$231M | $10M | $444M |
| Investing Cash Flow | -$40.4B | -$15.9B | -$193M | -$74M | $466M |
| — Financing Activities — | |||||
| Net Debt Issuance | $15.0B | -$27.8B | -$1.9B | -$265M | $500M |
| Stock Repurchased | $0 | $0 | -$62M | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$778M | -$611M | -$130 | $150 | -$227M |
| Financing Cash Flow | $61.5B | $13.6B | -$2.0B | -$265M | $273M |
| Net Change in Cash | $14.0B | -$13.9B | -$3.2B | -$373M | -$4.8B |
| Cash End of Period | $23.2B | $9.3B | $6.1B | $5.7B | $902M |
| Free Cash Flow | -$9.5B | -$11.8B | -$1.4B | -$117M | -$5.6B |